Dossier
generic formulation
Coverage of generic formulation in the Nexus archive.
- Spinal Muscular Atrophy drug: regulatory approval should guide Kerala’s procurement policy, say experts
Experts argue that Kerala should prioritize procuring a regulatory-approved generic formulation of the Spinal Muscular Atrophy drug over the original molecule, which is significantly more expensive. B. Ekbal highlights the cost disparity, stating the generic version is available at a fraction of the price.